Semaphorins and their receptors: Novel features of neural guidance molecules
スポンサーリンク
概要
- 論文の詳細を見る
Semaphorins were originally identified as axon guidance cues involved in the development of the nervous system. In recent years, it is emerging that they also participate in various biological systems, including physiological and pathological processes. In this review, we primarily focus on our cumulative findings for the role of semaphorins and their receptors in the regulation of the immune system, while also summarizing recent progress in the context of cardiovascular system.(Communicated by Takao SEKIYA, M.J.A.)
著者
-
Kumanogoh Atsushi
Department of Immunopathology, Research Institute for Microbial Diseases, Osaka University
-
Kikutani Hitoshi
World Premier International Immunology Frontier Research Center, Osaka University
-
Kumanogoh Atsushi
Department Of Immunopathology Immunology Frontier Research Center (ifrec) Research Institute For Mic
関連論文
- Semaphorins and their receptors: Novel features of neural guidance molecules
- CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
- Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment
- Plexin-A4 negatively regulates T lymphocyte responses
- Bimodal regulation of T cell-mediated immune responses by TIM-4
- Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals
- Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72 : implications for the regulation of immune and inflammatory responses
- The study of cytokines by Japanese researchers : a historical perspective
- OE-356 Novel Transmembrane Type Class VI Semaphorin, Sema6D Regulates Cardiac Morphogenesis Through PlexinA1(Development and Differentiation 2 (H) : OE45)(Oral Presentation (English))
- A case of Behcet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
- Drug-induced Thrombotic Thrombocytopenic Purpura Successfully Treated with Recombinant Human Soluble Thrombomodulin
- Tocilizumab for the Treatment of Patients With Refractory Takayasu Arteritis